This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fowell, A Articles by Russell, I T Search for Related Content PubMed PubMed Citation Articles by Fowell, A Articles by Russell, I T Social Bookmarking                         What's this?

Design of trials with dying patients: a feasibility study of cluster randomisation versus randomised consent

North West Wales NHS Trust

R Johnstone

North West Wales NHS Trust

I G Finlay

Cardiff University, Cardiff

D Russell

Institute of Medical and Social Care Research, University of Wales, Bangor

I T Russell

Institute of Medical and Social Care Research, University of Wales, Bangor

There is little rigorous evidence to underpin clinical guidelines for palliative care. However, research in palliative care is difficult, especially with dying patients. Consent is a major issue, since staff do not wish to invite dying patients to participate in trials. We, therefore, conducted a feasibility study in two units within the North West Wales NHS Trust. We explored two novel approaches to research in palliative care -cluster randomisation and randomised consent. All patients admitted to the two units during the study were asked for permission to use their data for research. We allocated the two units, at random, to use cluster randomisation or randomised consent for three months, and then to crossover to the other design. Of 24 patients dying during cluster-randomised phases, 13 gave consent on admission to use their data and were, thus, eligible to enter the trial; however, defined eligibility criteria reduced these to six active participants. Of 29 patients dying during randomised consent phases, seven gave consent on admission to use their data; although two were eligible for randomisation, neither entered the trial. We judge that cluster randomisation is the more effective design for research with dying patients. Computer simulation, based on data from 1500 dying patients on the Welsh Integrated Care Pathway, shows that crossover cluster trials need much smaller samples than simple cluster trials. Furthermore, this study has shown that crossover cluster trials are entirely feasible. We recommend a ‘definitive’ trial to test the crossover design more widely.

Key Words: clinical trials • cluster randomisation • crossover trials • informed consent • methodology • palliative care • randomised consent

Palliative Medicine, Vol. 20, No. 8, 799-804 (2006)
DOI: 10.1177/0269216306072554


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?